Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
There are solutions to help mitigate this issue
Sitthideatphaiboon P, Galan-Cobo A, Negrao M, Qu X, Poteete A, Zhang F, Liu D, Lewis W, Kemp H, Lewis J, Rinsurongkawong W, Giri U, Lee JJ, Zhang J, Roth J, Swisher S , Heymach
Aroda, M.D., from Brigham and Women's Hospital in Boston, and colleagues randomly assigned adults with type 2 diabetes inadequately controlled with diet and exercise to receive once-weekly subcutaneous cagrilintide 2.4 mg plus semaglutide 2.4 mg, cagrilintide 1.0 mg plus semaglutide 1.0 mg, or placebo for 40 weeks (62, 63, and 64 participants, respectively)
Other Ingredients: Purified water, Glycerol (INS 422), Sorbitol, Citric Acid (INS 330), Potassium Sorbate (INS 202), Sweetener (INS 955), and permitted natural synthetic food colour(s) (INS 104)
In Iranian patients, mean serum Cu and zinc levels were also significantly lower in patients with lower segmental and non-segmental vitiligo than in the control group [104]